PALB2 mutations in European familial pancreatic cancer families

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,026

Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Jones, S., Hruban, R. H., Kamiyama, M., Borges, M., Zhang, X., Parsons, D. W., Lin, J. C.-H., Palmisano, E., Brune, K., Jaffee, E. M., et al. (2009) · Science · doi:10.1126/science.1171202 · Cited by 826 · cited 2×

PALB2 is an integral component of the BRCA complex required for homologous recombination repair

Sy, S. M.-H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 643

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642

Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study

Canto, M. I., Goggins, M., Hruban, R. H., Petersen, G. M., Giardiello, F. M., Yeo, C., Fishman, E. K., Brune, K., Axilbund, J., Griffin, C., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.02.005 · Cited by 524

BRCA2 germline mutations in familial pancreatic carcinoma

Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

Xia, B., Dorsman, J. C., Ameziane, N., de Vries, Y., Rooimans, M. A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1942 · Cited by 465

Effects of Misspecifying Genetic Parameters in Lod Score Analysis

Clerget‐Darpoux, F., Bonaïti‐Pellié, C., & Hochez, J. (1986) · Biometrics · doi:10.2307/2531059 · Cited by 439

Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.

Murphy, K. M., Brune, K. A., Griffin, C. A., Sollenberger, J. E., Petersen, G. M., Bansal, R. K., Hruban, R. H., & Kern, S. E. (2002) · PubMed · Cited by 435

Advances in counselling and surveillance of patients at risk for pancreatic cancer: Table 1

Brand, R. E., Lerch, M. M., Rubinstein, W. S., Neoptolemos, J. P., Whitcomb, D. C., Hruban, R. H., Brentnall, T. A., Lynch, H. T., & Canto, M. I. (2007) · Gut · doi:10.1136/gut.2006.108456 · Cited by 319

Pancreatic AdenocarcinomaPractice Guidelines in Oncology

Warren, R. S., Whiting, S. H., Willett, C. G., Wolff, R. A., Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben‐Josef, E., Benson, A. B., Berlin, J. D., et al. (2010) · Cited by 1

Single nucleotide polymorphisms and risk factors predictive of pancreatic adenocarcinoma

Martinez, E., Silvy, F., Lombardo, D., & Mas, E. (2016) · Cancer Cell & Microenvironment · doi:10.14800/ccm.1231 · Cited by 1

Clinical Genetic Testing in Gastroenterology

Goodman, R. P., & Chung, D. C. (2016) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2016.23 · Cited by 1

Development of a novel PTT assay for mutation detection in PALB2 large exons and PALB2 screening in medullary breast cancer

Πουμπουρίδου, Ν., Goutas, N. D., Tsionou, C., Dimas, K., Lianidou, E. S., & Κroupis, C. (2015) · Familial Cancer · doi:10.1007/s10689-015-9851-7 · Cited by 1

Pathology and Molecular Pathology of Pancreatic Cancer

Foo, W. C., & Wang, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_26 · Cited by 1

Pancreatic Cancer Epidemiology and Environmental Risk Factors

Yellu, M., Kamireddy, C., & Olowokure, O. O. (2017) · Springer eBooks · doi:10.1007/978-3-319-58256-6_1 · Cited by 1

The p.Ser64Leu and p.Pro104Leu missense variants of PALB2 identified in familial pancreatic cancer patients compromise the DNA damage response

Zhang, Y., Park, J., Zhang, F., Olson, S. H., Orlow, I., Li, Y., Kurtz, R. C., Ladanyi, M., Chen, J., Toland, A. E., et al. (2020) · Human Mutation · doi:10.1002/humu.24133 · Cited by 1

Hereditary Syndromes and Pancreatic Cancer

Pölsler, L., Claes, K., & Zschocke, J. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_3 · Cited by 1

Familiäres Pankreaskarzinom

Langer, P., & Bartsch, D. K. (2013) · Springer eBooks · doi:10.1007/978-3-642-37964-2_63 · Cited by 1

PERSONALIZED APPROACH TO ADJUVANT CHEMOTHERAPY IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

Tsyganov, M. M., Родионов, Е. О., Ibragimova, М. K., Тузиков, С. А., & Litvyakov, N. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.32 · Cited by 1

INNOVATIVE APPROACHES TO DEVELOPMENT OF GEROPROTECTORS-PHYTOADAPTOGENS FOR PREVENTIVE ONCOLOGY AND AGE-RELATED PATHOLOGIES

Bocharova, O. A., Карпова, Р. В., Бочаров, Е. В., Aksenov, A. A., Chulkova, S. V., Kucheryanu, V. G., Kazeev, I. V., Revischin, A., Pavlova, G. P., Shevchenko, V. E., et al. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.17 · Cited by 1

Characteristics of familial pancreatic cancer families with additional colorectal carcinoma

Lehman, B., Matthäi, E., Krasser‐Gercke, N., Denzer, U. W., Figiel, J. H., Hess, T., Slater, E. P., & Bartsch, D. K. (2023) · Familial Cancer · doi:10.1007/s10689-023-00328-1 · Cited by 1

Clinical Genetics for the Gynecologist

Grignol, V. P., & Agnese, D. M. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7641-6_19 · Cited by 1

Familial Cancer of the Pancreas

Bartsch, D. K., Fendrich, V., & Langer, P. (2015) · Wiley eBooks · doi:10.1002/9781118307816.ch3

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Chevrier, S., & Boidot, R. (2014) · Journal of Visualized Experiments · doi:10.3791/51902

Molecular Therapeutics: Pancreatic Cancer

Fogelman, D. R., Javle, M. M., & Abbruzzese, J. L. (2015) · Wiley eBooks · doi:10.1002/9781118468678.ch26

Le cancer du pancréas et la génétique

Boumendjel, S. (2015) · ONCOLOGIE · doi:10.1007/s10269-015-2527-y

Pankreaskarzinom

Obermair, F., Popper, U., Romeder, F., & Rumpold, H. F. (2016) · Wiener klinisches Magazin · doi:10.1007/s00740-016-0107-4 · Cited by 1

Evaluation and Surveillance Strategies for Patients at Increased Risk of Pancreatic Cancer

Nayor, J., Grover, S., & Syngal, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19677-0_15

Strategies to Target Pancreatic Cancer

Liou, G., & Störz, P. (2016) · Springer eBooks · doi:10.1007/978-3-319-31254-5_1

Genetic Counseling

Purandarey, H. (2009) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10279_17

Identifying Susceptibility Genes for Familial Pancreatic Cancer Using Novel High-Resolution Genome Interrogation Platforms

Al-Sukhni, W. (2012) · TSpace (University of Toronto)

PALB2 mutations in familial breast and pancreatic cancer Erin W. HofstatterSusan M. DomchekAlexander Miron • Judy GarberMolin WangKathryn ComponeschiLeigh Boghossian • Penelope L. MironKatherine L. NathansonNadine Tung

Hofstatter, E. W., Domchek, S. M., Boghossian, L., Nathanson, K. L., Miron, A., Miron, P. L., Garber, J. E., Wang, M., Componeschi, K. P., & Tung, N. L. (2011)

Radiofrequency Ablation of Pancreatic Mass

Girelli, R., Frigerio, I. M., Giardino, A., Regi, P., Scopelliti, F., & Butturini, G. (2017) · Springer eBooks · doi:10.1007/978-3-319-42358-6_3

Hereditary Pancreatic Cancer

Borazanci, E. H., & Haag, S. (2017) · InTech eBooks · doi:10.5772/65067

Neoplasia of the Gastrointestinal Tract

Margalit, O., & DuBois, R. N. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch31

Screening of Patients with Hereditary Pancreatic Cancer

Goggins, M. (2018) · Wiley eBooks · doi:10.1002/9781119188421.ch98

Identification of the best index case significantly improves mutation detection rates in families with hereditary breast and ovarian cancerPreprint

Wyrwoll, M. J., Fuchs, L., & Waschk, D. E. J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/527168

Identifizierung von Patientinnen und Patienten mit der hereditären Form des Mamma- und Ovarialkarzinoms mittels Next-Generation-Sequencing-(NGS)-Technologie

Smogavec, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7487

A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

PrACtiCe, A. (2014)

Pathogenesis, Epidemiology, and Prognosis of Pancreatic Adenocarcinomas

Kim, K. K., Gaddam, S., & Liu, Q. Y. (2021) · Hepato-Pancreato-Biliary Malignancies · doi:10.1007/978-3-030-37482-2_28-1

Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma

Lew, D., & Kwok, K. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-37482-2_29-1

Familial Pancreatic Cancer

Roberts, N. J., & Wood, L. D. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_4

Science and education in XXI century. Vol. 1

(2014) · Consulting company Ucom eBooks · doi:10.17117/2014.10.31.01

Desregulación del splicing del gen PALB2 en cáncer de mama hereditario

Valenzuela‐Palomo, A. (2022) · doi:10.35376/10324/55378

Germline Testing for Individuals with Pancreatic Adenocarcinoma and Novel Genetic Risk Factors

Chittenden, A. B., Haraldsdóttir, S., Chen, E., & Nissim, S. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.07.008

ANTIBODY-FREE CHIMERIC FLT3-CAR RECEPTOR FOR TARGETING THE FLT3 RECEPTOR, A MARKER OF POOR PROGNOSIS IN ACUTE MYELOID LEUKEMIA

Mayorova, V. E., Mollaev, M. D., Вихрева, П. Н., Kulakovskaya, E. A., Pershin, D., Кибардин, А. В., Maschan, M. A., & Larin, S. S. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.35

ANALYSIS OF IMMUNOHISTOCHEMICAL REACTIONS OF VARIOUS PD-L1 CLONES IN PROSTATE ADENOCARCINOMA

Kalfa, М. А., Golubinskaya, E. P., Makalish, T. P., Zyablitskaya, E. Y., & Kubyshkin, A. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.38

PECULIARITIES OF INFLUENCE MADE BY DIABETES MELLITUS AS COMORBID PATHOLOGY ON THE SYSTEM OF SEX HORMONES AND THEIR RECEPTORS IN TUMORS OF DIFFERENT HISTOLOGICAL ORIGIN

Frantsiyants, E. M., Surikova, E. I., Bandovkina, V. A., Kaplieva, I. V., Pogorelova, Y. A., Neskubina, I. V., Cheryarina, N. D., Trepitaki, L. K., Морозова, М. И., Kotieva, I. M., et al. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.28

FEATURES OF EXPRESSION OF TRANSFORMING GROWTH FACTOR BETA IN ESTROGEN-POSITIVE BREAST CANCER

Анатольевна, Д. Т., Николаевна, Б. Н., Slonimskaya, E. M., & Cherdyntseva, N. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.33

MECHANISMS OF RESISTANCE IN THERAPY WITH ANGIOGENESIS BLOCKERS IN COLORECTAL CANCER

Golubinskaya, E. P., Seferov, B. D., Kalfa, М. А., Фомочкина, И. И., & Kubyshkin, V. А. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.37

CIRCULATING DISIALOGANGLIOSIDE GD2 IN NEUROBLASTOMA DIAGNOSIS

Mollaev, M. D., Ivanov, N. S., Литвин, Е. А., Kara, V. V., Kholodenko, R. V., Maschan, M. A., Kachanov, D. Y., Shamanskaya, T. V., & Larin, S. S. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.34

A NEW MUTATION IN THE PALB2 GENE ASSOCIATED WITH HEREDITARY BREAST CANCER IN A YOUNG PATIENT BELONGING TO THE YAKUT ETHNIC GROUP

Molokov, A. Y., Анатольевна, Г. П., Zarubin, А. А., Тихонов, Д., & Cherdyntseva, N. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.39

PROSPECTS FOR THE USE OF MOLECULAR GENETIC MARKERS TO IMPROVE DIAGNOSTICS AND TARGETED THERAPY OF MELANOMA

Khripko, O. P., Khripko, Y. I., Deulin, I. Y., Владимировна, К. Е., & Zakharov, V. N. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.40

PRODUCTION AND LARGE-SCALE EXPANSION OF FUNCTIONALLY ACTIVE NK CELLS SUITABLE FOR USE IN IMMUNOTHERAPY OF HEMATOLOGICAL AND SOLID TUMORS

Игоревна, Л. М., Вихрева, П. Н., Кибардин, А. В., Maschan, M. A., & Larin, S. S. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.36

XENON-OXYGEN THERAPY AS A FACTOR OF NORMALIZATION OF ADAPTIVE AND PSYCHO-EMOTIONAL STATUS IN PATIENTS DIAGNOSED WITH CERVICAL CANCER AT THE SURGICAL STAGE OF ANTITUMOR TREATMENT

Popova, N. N., Shikhlyarova, A. I., Rozenko, D. A., Вартанович, Т. С., Shepelenko, A. V., Korobov, A. А., Netyvchenko, N. V., Sugak, E. Y., & Ardzha, A. Y. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.29

LITHIUM EFFECT ON AUTOPHAGY AND CELL DEATH IN SKIN MELANOMA

Taskaeva, I. S., Gogaeva, I., Shatruk, A., & Bgatova, N. P. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.14

RADIODYNAMIC AND CONTACT RADIATION THERAPY OF INOCULATED TUMOR IN AN IN VIVO EXPERIMENT

Tserkovsky, D. A., Protopovich, E. L., Mazurenko, A. N., & Borichevsky, F. F. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.3

ENERGY PHENOTYPES OF BT20, BT474, MDA-MB-453 UNDER ACTIONS AND EFFECTS MADE BY BERBERINE

Timofeeva, S. V., Filippova, S. Y., Sitkovskaya, A. O., Межевова, И. В., Enin, Y. S., Shamova, T. V., & Гненная, Н. В. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.20

THE IMMUNE SYSTEM AND MALIGNANT NEOPLASMS: FUNDAMENTAL AND TRANSLATIONAL ASPECTS

Cherdyntseva, N. V., Анатольевна, Г. П., Ivanyuk, E. E., Ivanova, A. A., Molokov, A. Y., Ponomareva, A. A., Ermak, N. E., & Buldakov, M. A. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.7

GALLO-ELLAGI-TANNINS OF CHAMAENERION ANGUSTIFOLIUM: ANTITUMOR ACTIVITY

Sasov, S. A., Totoeva, N. N., Фадеев, Н. Б., Масляков, В. Ю., & Gusev, D. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.23

IMPLEMENTATION OF THE PRINCIPLES OF ACTIVATION ELECTROMAGNETOTHERAPY IN EXPERIMENTAL ONCOLOGY

Zhukova, G. V., Shikhlyarova, A. I., Sheĭko, E. A., Gudtskova, T. N., Zernov, V. A., & Rudenko, M. Y. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.6

ABNORMALITIES IN NATURAL LIGHT REGIMEN AS TRIGGER OF TUMOR GROWTH

Vinogradova, I. A., & Anisimov, V. N. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.24

EXTRACELLULAR MATRIX OF EXPERIMENTAL HEPATOCARCINOMA G-29 UNDER THE INFLUENCE OF LITHIUM CARBONATE

Makarova, V. V., & Bgatova, N. P. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.25

PDX MODEL OF BC IN THE STUDY OF PLASTICITY OF TUMOR CELLS IN THE PROCESS OF METASTASIZING

Bokova, U. A., Tretyakova, M. S., Frolova, A. A., Валерьевич, А. В., Сергеевна, А. Е., Cherdyntseva, N. V., Михайлович, П. В., & Владимирович, Д. Е. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.4

SELF-DEPENDENT ANTITUMOR EFFECTS PRODUCED BY METAL-CONTAINING NANOPARTICLES IN IN VIVO EXPERIMENTS

Zhukova, G. V., Goroshinskaya, I. A., Kachesova, P. S., Zlatnik, E. Y., Shikhlyarova, A. I., Zernov, V. A., Rudenko, M. Y., Novikova, I. A., & Kit, O. I. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.15

EVALUATION OF CYTOTOXICITY AND PRO-APOPTOTIC EFFECTS OF NEW CYP17A1 INHIBITORS

Khan, I. I., Aidosov, C. M., Krivchenko, V. O., Latysheva, А. S., Zolottsev, V. А., Misharin, A. Y., & Pokrovsky, V. S. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.19

INTERMITTENT FASTING AND INTERVAL HYPOXIC TRAINING FOR ACTIVATION OF ADAPTIVE RESERVES OF THE BODY, PREVENTION AND TREATMENT OF DEGENERATIVE BRAIN DISEASES

Voronina, T. N. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.8

STUDY OF THE ANTITUMOR ACTIVITY OF THE LIPOSOMAL FORM OF THE GLYCOLYSIS INHIBITOR IODOACETATE IN THE LEWIS LUNG CARCINOMA MODEL

Korshunov, D. A., Bukterov, M. V., Milto, I. V., & Кондакова, И. В. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.13

THE ROLE OF NUTRITIONAL RESTRICTION IN THE PATHOGENESIS OF MALIGNANT TUMORS

Fefelova, Y. A. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.5

THE ROLE OF THE SYSTEM OF INSULIN-LIKE GROWTH FACTORS IN BLOOD IN SOFT TISSUE SARCOMAS

Goroshinskaya, I. A., Kaplieva, I. V., Алексановна, С. С., Frantsiyants, E. M., Vashchenko, L. N., Pogorelova, Y. A., Trepitaki, L. K., Ausheva, T. V., & Витальевич, Ч. П. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.27

MITOCHONDRIAL DYSFUNCTION UNDER THE GROWTH OF B16/F10 MELANOMA IN C57BL/6 MICE

Kit, O. I., Frantsiyants, E. M., Neskubina, I. V., Kaplieva, I. V., Shikhlyarova, A. I., Trepitaki, L. K., Nemashkalova, L. A., & Pogorelova, Y. A. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.9

PLASMONIC PHOTOTHERMAL THERAPY IN EXPERIMENTAL ONCOLOGY: PROBLEMS AND PROSPECTS

Bucharskaya, A. B., Maslyakova, G. N., Наволокин, Н. А., Мудрак, Д. А., Khlebtsov, N. G., Khlebtsov, B. N., Genin, V. D., Genina, E. A., & Tuchin, V. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.16

EFFECACY OF ANTISENSE OLIGONUCLEOTIDE HUSH-11 WITH THIOPHOSPHATE IN TREATMENT OF MELANOMA IN MICE

Yurchenko, K. A., & Oberemok, V. V. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.21

DISCOVERY OF ADAPTATIONAL REACTIONS: A NEW MILESTONE IN THE DEVELOPMENT OF ONCOLOGY

Shikhlyarova, A. I. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.1

NEW CHALLENGE TO CANCER AND LONGEVITY

Inui, T. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.2

PECULIARITIES OF THE COURSE OF LEWIS LUNG EPIDERMOID CARCINOMA IN MICE INFECTED WITH MYCOBACTER TUBERCULOSIS

Kudriashov, G., Tochilnikov, G. V., Zmitrichenko, Y. G., Krylova, Y. S., Nefedov, A. O., Догонадзе, М. З., Zabolotnykh, N. V., Dyakova, M., Esmerdyaeva, D. S., Vitovskaya, M. L., et al. (2022) · Cardiometry · doi:10.18137/cardiometry.2022.24.conf.10

Diagnosis and Evaluation of Pancreatic and Periampullary Adenocarcinoma

Lew, D., & Kwok, K. K. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_29

Imaging-Based Biomarkers for Pancreatic Cancer

Thomas, J., Douglas, J. E., & Koay, E. J. (2022) · Springer eBooks · doi:10.1007/978-3-031-05724-3_19

Pathogenesis, Epidemiology, and Prognosis of Pancreatic Adenocarcinomas

Kim, K. K., Gaddam, S., & Liu, Q. Y. (2022) · Springer eBooks · doi:10.1007/978-3-030-41683-6_28

Ductal Adenocarcinoma and Pancreatic Intraepithelial Neoplasia

(2023) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477275-07

Pancreatic Cancer: A Review on Pathophysiology, Naturopathy, Clinical Treatment and Outcomes

Chakraborty, R., Dutta, A., Baruah, B. J., Kumari, R., Sarma, P., Sharma, A., Goswami, K., Myakala, H., & Verma, A. K. (2023) · Current Cancer Therapy Reviews · doi:10.2174/1573394719666230830125213

Investigation of the germline PALB2 variants in cancer patients using the next-generation sequencing in Türkiye

Tunçer, Ş. B., Kılıç, S., Erdoğan, Ö. Ş., Çelik, B., Kayım, Z. Y., & Gültaslar, B. K. (2023) · Adıyaman Üniversitesi Sağlık Bilimleri Dergisi · doi:10.30569/adiyamansaglik.1378620

Targeting pancreatic cancer screening by identification of pathogenic variants of BRCA2/ BRCA1 in healthy individuals who have no known family history of pancreatic cancer: The arguments for and against.

Earl, J., Kataki, A., Canzian, F., Costello, E., Campa, D., & Greenhalf, W. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.001

Altérations génétiques au sein de la séquence nucléotidique des VNTR de la lipase sels biliaires-dépendante : relation avec le cancer du pancréas

Martinez, E. (2015) · theses.fr (ABES) · doi:10.70675/649058c2z6534z4fbczbc09zc5475d737e9b

Nouvelle approche expérimentale en génétique constitutionnelle des maladies humaines

Bouchtaoui, M. E. (2018) · theses.fr (ABES) · doi:10.70675/a55ec0eez4b07z4530zb26bz7bdc408ee389

Pancreatic cancer: Recent epidemiological trends and risk determinants

Hudgi, A., Woodcock, A., Mirza, A., Okiye, P., Kemple, B., Sifuentes, H., & Sridhar, S. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.119810 · Cited by 1

Hereditary Pancreatic Cancer: Genetic Risk, Surveillance Strategies, and Therapeutic Implications

Marafioti, M., Patruno, M., Musarra, M., Silvestris, N., Funes, J. A. P., Omero, F., Sapuppo, E., Cianci, V., Calabrò, M., Irrera, N., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146404

Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated

Harinck, F., Kluijt, I., van Mil, S. E., Waisfisz, Q., van Os, T. A. M., Aalfs, C. M., Wagner, A., Olderode-Berends, M. J. W., Sijmons, R. H., Kuipers, E. J., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2011.226 · Cited by 42

PALB2 mutations in familial breast and pancreatic cancer

Hofstatter, E. W., Domchek, S. M., Miron, A., Garber, J. E., Wang, M., Componeschi, K. P., Boghossian, L., Miron, P. L., Nathanson, K. L., & Tung, N. (2011) · Familial Cancer · doi:10.1007/s10689-011-9426-1 · Cited by 155

Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases

Blanco, A., de la Hoya, M., Osório, A., Dı́ez, O., Miramar, M. D., Infante, M., Martínez-Bouzas, C., Torres, A., Lasa, A., Llort, G., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067538 · Cited by 54

PALB2 mutations in familial breast and pancreatic cancer Erin W. HofstatterSusan M. DomchekAlexander Miron • Judy GarberMolin WangKathryn ComponeschiLeigh Boghossian • Penelope L. MironKatherine L. NathansonNadine Tung

Hofstatter, E. W., Domchek, S. M., Boghossian, L., Nathanson, K. L., Miron, A., Miron, P. L., Garber, J. E., Wang, M., Componeschi, K. P., & Tung, N. L. (2011)

Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation

Vietri, M. T., Caliendo, G., Schiano, C., Casamassimi, A., Molinari, A. M., Claudio Napoli, A., & Cioffi, M. (2015) · Familial Cancer · doi:10.1007/s10689-015-9786-z · Cited by 27